Sabra Health Care REIT Inc
XBER:SBC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sabra Health Care REIT Inc
XBER:SBC
|
US |
|
Warner Bros Discovery Inc
NASDAQ:WBD
|
US |
|
R
|
Roper Technologies Inc
SWB:ROP
|
US |
|
I
|
Infineon Technologies AG
MIL:IFX
|
DE |
|
Hays PLC
LSE:HAS
|
UK |
|
PSP Swiss Property AG
OTC:PSPSF
|
CH |
|
K
|
Kulicke and Soffa Industries Inc
F:KU1
|
SG |
|
M
|
Molson Coors Beverage Co
SWB:NY7
|
US |
Wall St Price Targets
SBC Price Targets Summary
Sabra Health Care REIT Inc
According to Wall Street analysts, the average 1-year price target for SBC is 20.3 EUR with a low forecast of 17.36 EUR and a high forecast of 23.75 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SBC's stock price target?
Price Target
20.3
EUR
According to Wall Street analysts, the average 1-year price target for SBC is 20.3 EUR with a low forecast of 17.36 EUR and a high forecast of 23.75 EUR.
What is the Revenue forecast for Sabra Health Care REIT Inc?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 5%.
What is the Operating Income forecast for Sabra Health Care REIT Inc?
Projected CAGR
12%
Over the last 14 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 3 years is 12%.
What is the Pre-Tax Income forecast for Sabra Health Care REIT Inc?
Projected CAGR
17%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 20%. The projected CAGR for the next 3 years is 17%.
What is the Net Income forecast for Sabra Health Care REIT Inc?
Projected CAGR
17%
Over the last 14 years, the compound annual growth rate for Net Income has been 20%. The projected CAGR for the next 3 years is 17%.
